Tissue Regenix Group PLC (LON:TRX) shares passed above its 50 day moving average during trading on Monday . The stock has a 50 day moving average of $1.09 and traded as high as $1.65. Tissue Regenix Group shares last traded at $1.60, with a volume of 19,204,973 shares changing hands.
The company has a debt-to-equity ratio of 20.22, a quick ratio of 3.41 and a current ratio of 4.08. The company has a market cap of $14.94 million and a price-to-earnings ratio of -1.82. The company has a fifty day moving average of GBX 1.14 and a two-hundred day moving average of GBX 2.60.
About Tissue Regenix Group (LON:TRX)
Tissue Regenix Group plc, a medical technology company, develops and commercializes platform technologies in the field of tissue engineering and regenerative medicine in the United States and internationally. It operates through BioSurgery, Orthopaedics & Dental, and Cardiac divisions. The company's decellularisation (dCELL) technology removes DNA and other cellular material from animal and human tissue leaving intact an inert acellular matrix upon which the patient's cells can repopulate.
Receive News & Ratings for Tissue Regenix Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tissue Regenix Group and related companies with MarketBeat.com's FREE daily email newsletter.